Maya C. André - Concepedia

Author

Maya C. André

University Children's Hospital Tübingen ORCID

Also Known As

M Andre, M C André, M. C. André, M.C. Andre, Mauricio Lutzky André, Maya Andre, Maya André, Maya C Andre, Maya C André, Maya C. Andre

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University Children's Hospital Tübingen University Children’s Hospital Basel University of Tübingen University Medical Center of the Johannes Gutenberg University Mainz Johannes Gutenberg University Mainz

About

Maya C. André is an author at University Children's Hospital Tübingen specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	494
2	Health Sciences	2	2	107
3	Engineering	1	1	89
4	Public Health	1	1	16
5	Biochemistry	1	1	31

Maya C. André

Publications

916

Citations

H-Index

Page 1

	Year	Citations
Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling Stefanie Bugl, Stefan Wirths, Markus P. Radsak, Blood	2012	100
CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies Alexandra Martyniszyn, Ann-Christin Krahl, Maya C. André, Human Gene Therapy	2017	94
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging Binje Vick, Maja Rothenberg, Nadine Sandhöfer, PLoS ONE Cell TherapyEngineeringMixed-phenotype Acute LeukemiaImmunologyImmunotherapy	2015	89
Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells Maya C. André, Annika Erbacher, Christian Gille, The Journal of Immunology Cell TherapyLymphocyte DevelopmentImmunologyImmune RegulationNsg-derived Nk Cells	2010	76
An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia Samuel Koerner, Maya C. André, Josef Leibold, Leukemia Hematological MalignancyCell TherapyMalignant Blood DisorderImmunologyNk Cell Reactivity	2016	54
High Proportion of Leukemic Stem Cells at Diagnosis Is Correlated with Unfavorable Prognosis in Childhood Acute Myeloid Leukemia Kai-Erik Witte, Jörg Ahlers, Iris Schäfer, Pediatric Hematology and Oncology	2011	49
Monocytes derived from humanized neonatal NOD/SCID/IL2Rγnull mice are phenotypically immature and exhibit functional impairments Christian Gille, Thorsten Orlikowsky, Baerbel Spring, Human Immunology InflammationCytokineKnockout MouseDevelopmental BiologyAutoimmune Disease	2012	48
EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia Martina Konantz, Maya C. André, Martin Ebinger, Leukemia Hematological MalignancyTumor BiologyMedicineMalignant Blood DisorderMixed-phenotype Acute Leukemia	2012	47
LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis Tatsuya Morishima, Ann-Christin Krahl, Masoud Nasri, Blood	2019	43
Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome Jeanette Woiterski, Martin Ebinger, Kai Witte, International Journal of Cancer	2013	41

Page 1